| Literature DB >> 28672932 |
Chuan Wang1,2, Yi Xin2, Na Li2, Diankun Li1,2, Jingxing Li1, Chengxiong Gu1.
Abstract
Effective therapies for preventing perioperative complications such as thrombosis and inflammation after coronary endarterectomy (CE) are lacking. Electrocoagulation electrotomes have been routinely used in surgery for their cutting, clotting, and hemostatic properties. As strong flattening tools, their electrocautery function may prevent mechanical intimal-adventitial injury to arterial circulation and attenuate stenosis. The present study investigated the effects of intravascular application of electrocautery on ameliorating inflammation and thrombosis in a rabbit model of abdominal aortic endarterectomy. New Zealand rabbits were randomly divided into the sham, control (endarterectomy), and study (endarterectomy + electrocautery) groups with 10 in each group. Abdominal aortas were partially blocked and intima was removed. Electrocautery was performed with an electrocoagulation electrotome through the entire blocked vessel lumen. Vascular ultrasound parameters, molecular biological and histological characteristics of the abdominal aorta including vascular diameter, blood flow velocity, serum interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) levels, and apoptosis rate of vascular endothelial cells (ECs) were evaluated postoperatively by vascular Doppler ultrasound, ELISA, real-time RT-PCR, flow cytometry, and immunofluorescence at various time points. Compared with the endarterectomy + electrocautery group, the isolated endarterectomy group had significantly increased levels and gene expression of TNF-α and IL-6 (P<0.05), and rates of apoptosis of vascular ECs (P<0.05), with gradual vascular stenosis and decreased blood flow velocity. In conclusion, intravascular application of electrocautery has favorable short-term effects on the abdominal aorta and can reduce inflammation in a rabbit model of abdominal aorta endarterectomy. Long-term anti-inflammatory and anti-thrombotic effects on arterial remodeling and the clinical value of electrocautery in CE remain to be determined.Entities:
Keywords: electrocautery; endarterectomy; inflam-matory response; thrombosis
Year: 2017 PMID: 28672932 PMCID: PMC5488505 DOI: 10.3892/etm.2017.4460
Source DB: PubMed Journal: Exp Ther Med ISSN: 1792-0981 Impact factor: 2.447
Figure 1.Procedure of electrocautery.
Figure 2.Measurement of blood flow velocity and artery diameter.
The sequence of PCR primers.
| Gene | DNA sequence ( | Product size (bp) |
|---|---|---|
| TNF-α | U: ACCCTCACACTCAGATCATCTTCT | 422 |
| D: CAGATTGACCTCAGCGCTGAGTTG | ||
| IL-6 | U: GTCTATACCACTTCACAAGTCGGA | 441 |
| D: TTGGATGGTCTTGGTCCTTAGCCA | ||
| α-actin | U: GAAATCGTGGGTGACATCAAA | 478 |
| D: ACTCATCGTACTCCTGCTTGCTGA |
PCR, polymerase chain reaction; TNF-α, tumor necrosis factor-α; IL-6, interleukin-6; U, upstream; D, downstream.
Figure 3.Electrocautery plan option (immunofluorescence compassion).
Figure 4.Electrocautery plan option (visual compassion).
Figure 5.Immunofluorescence staining of three groups at (A) day 0, (B) day 1, (C) day 3, (D) day 7 and (E) day 20.
Figure 6.Apoptosis rate of vascular ECs. ECs, endothelial cells.
Figure 7.(A) TNF-α and (B) IL-6 protein expression in different groups. TNF-α, tumor necrosis factor-α; IL-6, interleukin-6.
Figure 8.TNF-α (A) and IL-6 (B) mRNA expression in different group. TNF-α, tumor necrosis factor-α; IL-6, interleukin-6.